$XRAY Cashflow Statement | Understand Stock

$XRAY

$9.35 +$0.13 (1.41%) Close

$XRAY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation
Amortization of intangible assets
Fixed asset impairment
Goodwill impairment
Intangible asset impairment
Deferred income taxes
Stock-based compensation expense
Restructuring and other costs
Other non-cash (income) expense
Loss (gain) on sale or disposal of non-strategic businesses and product lines
Loss (gain) on disposal of property, plant and equipment
Changes in operating assets and liabilities:
Accounts and notes receivable-trade, net
Inventories, net
Prepaid expenses and other current assets
Other noncurrent assets
Accounts payable
Accrued liabilities
Income taxes
Other noncurrent liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Cash paid for acquisitions of businesses and equity investments, net of cash acquired
Cash received on sale of non-strategic businesses or product lines
Capital expenditures
Cash received on derivative contracts
Proceeds from sale of property, plant and equipment
Cash paid on derivative contracts
Other investing activities, net
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from long-term borrowings
Cash paid for deferred financing costs
Repayments on long-term borrowings
Payments on terminated derivative instruments
Proceeds from exercised stock options
Proceeds from 364-day bridge loan
Repayment of 364-day bridge loan
(Repayments) proceeds on other short-term borrowings, net
Cash paid for treasury stock
Cash dividends paid
Other financing activities, net
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures of cash flow information:
Interest paid, net of amounts capitalized
Income taxes paid, net of refunds
Non-cash investing activities:
Change in accounts payable related to capital expenditures
Exchange of inventory for naming rights

Comments